Codexis (CDXS) Accounts Payables (2010 - 2026)
Codexis (CDXS) posted quarterly Accounts Payables of $2.1 million for Q1 2026, down 64.82% year-over-year from $6.0 million in Q1 2025, and up 36.87% quarter-over-quarter from $1.6 million in Q4 2025.
Codexis (CDXS) Accounts Payables (2010 - 2026) Analysis & Trends
Codexis' Accounts Payables history runs 17 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 64.82% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 64.82% YoY), while the FY2025 annual figure was $1.6 million, down 45.24% from the prior year.
- Accounts Payables for Q1 2026 stood at $2.1 million, up from $1.6 million in the prior quarter.
- The five-year high for Accounts Payables was $6.0 million in Q1 2025, with the low at $1.5 million in Q2 2025.
- The 5-year median for Accounts Payables is $3.1 million (2023), against an average of $3.2 million.
- The sharpest annual moves came in 2023 and 2026: Accounts Payables jumped 130.58% in 2023, then slumped 64.82% in 2026.
- Codexis' Accounts Payables stood at $3.2 million in 2022, then soared by 83.21% to $5.9 million in 2023, then sank by 52.28% to $2.8 million in 2024, then sank by 45.24% to $1.6 million in 2025, then soared by 36.87% to $2.1 million in 2026.
- Business Quant data shows CDXS's Accounts Payables at $2.1 million in Q1 2026, $1.6 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.61 Mn |
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 6.05 Mn |
| Dec 31, 2024 | 2.84 Mn |
| Sep 30, 2024 | 4.21 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | 3.47 Mn |
| Dec 31, 2023 | 5.95 Mn |
| Sep 30, 2023 | 3.10 Mn |
| Jun 30, 2023 | 4.04 Mn |
| Mar 31, 2023 | 4.49 Mn |
| Dec 31, 2022 | 3.25 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 3.28 Mn |